Cargando…
Evaluation of Excipient Risk in BCS Class I and III Biowaivers
The objective of this review article is to summarize literature data pertinent to potential excipient effects on intestinal drug permeability and transit. Despite the use of excipients in drug products for decades, considerable research efforts have been directed towards evaluating their potential e...
Autores principales: | Metry, Melissa, Polli, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817461/ https://www.ncbi.nlm.nih.gov/pubmed/34988701 http://dx.doi.org/10.1208/s12248-021-00670-1 |
Ejemplares similares
-
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers
por: Parr, Alan, et al.
Publicado: (2015) -
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin
por: Goodarzi, Navid, et al.
Publicado: (2016) -
Per-6-Thiolated Cyclodextrins: A Novel Type of Permeation
Enhancing Excipients for BCS Class IV Drugs
por: Asim, Mulazim Hussain, et al.
Publicado: (2020) -
Interchangeability Evaluation of Multisource Ibuprofen Drug Products Using Biowaiver Procedure
por: Shohin, I. E., et al.
Publicado: (2011) -
Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
por: Lenić, Ines, et al.
Publicado: (2019)